Campbell & Co Investment Adviser’s Pediatrix Medical MD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-10,539
Closed -$225K – 1222
2026
Q1
$225K Buy
+10,539
New +$219K 0.01% 943
2025
Q4
– Sell
-32,460
Closed -$544K – 1292
2025
Q3
$544K Sell
32,460
-22,451
-41% -$336K 0.04% 694
2025
Q2
$788K Buy
+54,911
New +$753K 0.05% 604
2025
Q1
– Sell
-69,622
Closed -$913K – 1207
2024
Q4
$913K Buy
+69,622
New +$961K 0.07% 427
2024
Q3
– Sell
-28,283
Closed -$214K – 1234
2024
Q2
$214K Buy
+28,283
New +$234K 0.02% 949
2024
Q1
– Sell
-96,163
Closed -$894K – 1272
2023
Q4
$894K Buy
96,163
+74,049
+335% +$766K 0.08% 435
2023
Q3
$281K Sell
22,114
-7,751
-26% -$106K 0.03% 739
2023
Q2
$424K Buy
29,865
+15,789
+112% +$222K 0.08% 507
2023
Q1
$210K Buy
+14,076
New +$213K 0.04% 723
2022
Q2
– Sell
-17,950
Closed -$421K – 819
2022
Q1
$421K Buy
+17,950
New +$439K 0.11% 346
2019
Q4
– Sell
-11,505
Closed -$260K – 764
2019
Q3
$260K Buy
+11,505
New +$262K 0.1% 451
2018
Q4
– Sell
-4,441
Closed -$207K – 433
2018
Q3
$207K Sell
4,441
-7,200
-62% -$331K 0.14% 331
2018
Q2
$504K Buy
+11,641
New +$558K 0.39% 63
2015
Q2
– Sell
-8,579
Closed -$622K – 205
2015
Q1
$622K Buy
8,579
+4,012
+88% +$279K 0.39% 97
2014
Q4
$302K Buy
+4,567
New +$279K 0.19% 159
2014
Q3
– Sell
-24,151
Closed -$1.4M – 225
2014
Q2
$1.4M Buy
+24,151
New +$1.42M 0.56% 73
2014
Q1
– Sell
-49,301
Closed -$2.63M – 259
2013
Q4
$2.63M Buy
+49,301
New +$2.65M 0.59% 65

Other funds holding MD

Campbell & Co Investment Adviser's MD Position: Q2 2026 in Review

Campbell & Co Investment Adviser sold out of Pediatrix Medical (MD) in Q2 2026, closing a stake of 10,539 shares — an estimated $225K sold.

Campbell & Co Investment Adviser first reported a position in MD in Q4 2013 and held it in 17 quarters. The position peaked at $2.63M in Q4 2013. 304 funds tracked by Wall St. Rank hold MD as of Q2 2026.

  • Campbell & Co Investment Adviser reported no remaining Pediatrix Medical position as of Q2 2026 after selling out during the quarter.
  • Campbell & Co Investment Adviser sold 10,539 Pediatrix Medical shares in Q2 2026, an estimated $225K.
  • Campbell & Co Investment Adviser first reported a position in Pediatrix Medical in Q4 2013 and held it in 17 quarters.
  • Campbell & Co Investment Adviser's Pediatrix Medical position peaked at $2.63M in Q4 2013.
  • 304 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2026.

Based on Campbell & Co Investment Adviser's 13F filing for Q2 2026, filed 3 Aug 2026.